Clinical trial
Treatment of Adult ALL With an MRD-directed Programme.
NCT00358072 · Northern Italy Leukemia Group, Other · Completed
Key facts
| NCT number | NCT00358072 |
|---|---|
| Title | Treatment of Adult ALL With an MRD-directed Programme. |
| Official title | Treatment of Adult Acute Lymphoblastic Leukemia Using a Post-remission Programme Whose Intensity Varies Depending on the Risk Class Defined on the Basis of Minimal Residual Disease. |
| Lead sponsor | Northern Italy Leukemia Group, Other |
| Collaborators | Associazione Italiana per la Ricerca sul Cancro |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Lymphoblastic Leukemia |
| Intervention type | Behavioral |
| Interventions | Postremission consolidation based on MRD status |
| Enrollment | 280 |
| Start date | May 1, 2000 |
| Primary completion | Dec 1, 2006 |
| Completion | Sep 1, 2008 |
| First posted | Jul 28, 2006 |
| Last update posted | Dec 29, 2010 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: